These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22927208)

  • 1. Preparation and evaluation of single and co-engineered combination inhalation carrier formulations for the treatment of asthma.
    Traini D; Adi H; Valet OK; Young PM
    J Pharm Sci; 2012 Nov; 101(11):4267-76. PubMed ID: 22927208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.
    Khan I; Al-Hasani A; Khan MH; Khan AN; -Alam FE; Sadozai SK; Elhissi A; Khan J; Yousaf S
    PLoS One; 2023; 18(3):e0281860. PubMed ID: 36913325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
    Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles.
    Gilani K; Najafabadi AR; Barghi M; Rafiee-Tehrani M
    J Pharm Sci; 2005 May; 94(5):1048-59. PubMed ID: 15793812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of high dose carrier based formulations.
    Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
    Int J Pharm; 2018 Jun; 544(1):141-152. PubMed ID: 29649519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
    Jetmalani K; Young PM; Smith T; Stewart P; Traini D
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1504-11. PubMed ID: 22335558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering drug ultrafine particles of beclomethasone dipropionate for dry powder inhalation.
    Xu LM; Zhang QX; Zhou Y; Zhao H; Wang JX; Chen JF
    Int J Pharm; 2012 Oct; 436(1-2):1-9. PubMed ID: 22732674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Dosing Cup Size on the Aerosol Performance of High-Dose Carrier-Based Formulations in a Novel Dry Powder Inhaler.
    Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
    J Pharm Sci; 2019 Feb; 108(2):949-959. PubMed ID: 30312722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler.
    Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
    AAPS PharmSciTech; 2019 Jan; 20(3):94. PubMed ID: 30690674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
    Pilcer G; Vanderbist F; Amighi K
    J Pharm Sci; 2009 Apr; 98(4):1463-75. PubMed ID: 18752304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes.
    Cabral-Marques H; Almeida R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):121-9. PubMed ID: 19446024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
    Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
    Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.